This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
This is a web analytics service.
Processing company
  • Google Ireland Limited
  • Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
  • Facebook Ireland Limited
  • 4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
  • advertising
  • Marketing
  • Retargeting
  • Analyse
  • Tracking
Technologies Used
  • Cookies
Data Attributes
  • Pixel specific data
  • Http-Header
  • Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • Facebook user ID
  • Browser information
  • Usage data
  • Geräteinformationen
  • Non-sensitive custom data
  • Referrer URL
  • Pixel ID
  • Location information
  • Pixel specific data
  • User behaviour
  • Ads viewed
  • Interactions with advertisement, services, and products
  • Marketing information
  • Content viewed
  • IP address
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Facebook Inc.
This is a web analytics service.
Processing company
  • Zoom Analytics Ltd.
  • Petah Tikva, Israel
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
Hemofarm marks 62nd anniversary
01. June 2022.
Hemofarm company has marked 62 years of successful operation and continuous growth under the slogan ‘Humanity is the Cure’. As the leading regional pharmaceutical company, Hemofarm looks upon caring for people’s health and promotion of humanity as its mission, indicating, by personal example, to their importance in the society.

‘Hemofarm is a legacy that we pass on from generation to generation, thus empowering our company. We have been constantly scoring a record-breaking production of medicines, while simultaneously preserving natural resources and operating in tune with the principles of sustainable development. It also involves caring for people, healthcare system, local community, and society in general. That is exactly the point – to work good for the better health of citizens, but also to help in other available ways. We must not forget that humanity is the cure, the special one that heals the body and the soul ‘, Dr Ronald Seeliger, CEO of the company, emphasized on the occasion of its anniversary.

From a small plant established in Vršac on 1 June 1960, with 30 employees at that time, Hemofarm has evolved to be a regional leader operating globally on four continents, with the current headcount of 3,600 people. After last year, when a record 287 million finished product packs were produced, Hemofarm has entered 2022 with even higher expectations - 300 million packs to come out of its plants this year, which would be a new production record of this company.

To mark the occasion, Stephan Eder, Executive Vice President of STADA Group in charge of European Markets and Germany, paid his first official visit to Hemofarm’s plants in Banjaluka and Vršac. ‘I am very glad to be here on this special day. I am aware that Hemofarm means a lot to patients, because it is a large and reliable provider of quality medicines that people can count on. I am impressed with how passionate and dedicated people at Hemofarm are in their approach to work, so that the medicines could reach the patients.’, Eder said.

Over the course of the past three decades, Hemofarm's laboratories have developed more than 300 pharmaceutical products registered throughout Europe and Asia, and 62 employees are currently engaged in the development of 46 new products. One of the biggest successes this year is the launch of ticagrelor, an extremely significant medicine in antiplatelet therapy, that Hemofarm developed in its laboratories, thus being the first company to launch it to the Serbian market after the originator.

Hemofarm has been constantly growing ever since its foundation, which would not have been possible without regular investments and constant innovations in pharmaceutical production. Since becoming a member of STADA group in 2006, this pharmaceutical company has invested as much as 385 million EUR in the modernization of its facilities, equipment, and new plants.

Reception for employees and children

The traditional reception that was held in Vršac-located factory to celebrate the anniversary has been marked by humanity this year: the company paid honour to its heroes among employees, jubilarians, voluntary blood donors, and food donors. In addition to health examinations provided to employees at several medical booths within the factory, an entertainment and educational program was organized for the children of employees this time. On this year’s company anniversary as well, in cooperation with the Blood Transfusion Institute of Vojvodina, Hemofarm employees voluntarily donated blood in a transfusion bus located inside the factory area. For this occasion, Hemofarm Foundation organized a special edition of the panel session ‘A Cup of Coffee with a Psychologist’ for employees.